Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease — Stella

Home/Common Variable Immunodeficiency/

View on ClinicalTrials.gov

Recruiting

Back to Common Variable Immunodeficiency trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Community Health 20, Birmingham, Alabama

Key details

Phase

Post-approval study

Sponsor

University of Alabama at Birmingham

Enrollment target

~22 participants

Started

January 2024

Primary completion

December 2026

Age range

21 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.